Yun Qu

ORCID: 0000-0001-6843-8170
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metal complexes synthesis and properties
  • Ferrocene Chemistry and Applications
  • DNA and Nucleic Acid Chemistry
  • Organometallic Complex Synthesis and Catalysis
  • Magnetism in coordination complexes
  • Advanced biosensing and bioanalysis techniques
  • Analytical chemistry methods development
  • CAR-T cell therapy research
  • Click Chemistry and Applications
  • Adsorption and biosorption for pollutant removal
  • Virus-based gene therapy research
  • HIV/AIDS drug development and treatment
  • Synthesis and Biological Evaluation
  • Lanthanide and Transition Metal Complexes
  • Synthesis and Characterization of Heterocyclic Compounds
  • Molecular Communication and Nanonetworks
  • Immunotherapy and Immune Responses
  • RNA and protein synthesis mechanisms
  • Micro and Nano Robotics
  • Inorganic and Organometallic Chemistry
  • Synthesis and biological activity
  • Chemical Synthesis and Analysis
  • Nanocluster Synthesis and Applications
  • Nanomaterials for catalytic reactions
  • Asymmetric Hydrogenation and Catalysis

City University of Hong Kong
2023-2024

Virginia Commonwealth University
2007-2023

University of Southern California
2011-2023

Research Institute of Dallas
2022-2023

Suzhou Municipal Hospital
2023

Nanjing Medical University
2021-2023

Taiyuan University of Technology
2020-2022

Nanyang Technological University
2022

Southern California University for Professional Studies
2021

Viterbo University
2021

The DNA-binding profile of a novel, trinuclear platinum Phase I clinical agent (BBR3464) is summarized. structure BBR3464 best described as two trans-[PtCl(NH3)2] units linked by tetra-amine [trans-Pt(NH3)2{H2N(CH2)6NH2}2]2+ unit. +4 charge BBR3464, the presence at least Pt coordination capable binding to DNA, and consequences such DNA are remarkable departures from cisplatin structural paradigm. chemical biological features argue that drug should be considered first representative an...

10.1021/bi990124s article EN Biochemistry 1999-05-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTA comparison of chemical reactivity, cytotoxicity, interstrand crosslinking and DNA sequence specificity bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogsNicholas Farrell, Y. Qu, L. Feng, B. Van HoutenCite this: Biochemistry 1990, 29, 41, 9522–9531Publication Date (Print):October 1, 1990Publication History Published online1 May 2002Published inissue 1 October...

10.1021/bi00493a005 article EN Biochemistry 1990-10-01

Abstract The delivery of nucleic acid vaccine to stimulate host immune responses against Coronavirus disease 2019 shows promise. However, vaccines have drawbacks, including rapid clearance and poor cellular uptake, that limit their therapeutic potential. Microrobots can be engineered sustain release further control the interactions with cells are vital for robust vaccination. Here, 3D fabrication biocompatible biodegradable microrobots via two‐photon polymerization gelatin methacryloyl...

10.1002/adhm.202202921 article EN Advanced Healthcare Materials 2023-05-09

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTCytotoxicity and antitumor activity of bis(platinum) complexes. A novel class platinum complexes active in cell lines resistant to both cisplatin 1,2-diaminocyclohexane complexesNicholas Farrell, Yun Qu, Miles P. HackerCite this: J. Med. Chem. 1990, 33, 8, 2179–2184Publication Date (Print):August 1, 1990Publication History Published online1 May 2002Published inissue 1 August...

10.1021/jm00170a021 article EN Journal of Medicinal Chemistry 1990-08-01

Despite the remarkable success of chimeric antigen receptor-modified T (CAR-T) cell therapy for blood malignancies, clinical efficacy this novel in solid tumor treatment is largely limited by immunosuppressive microenvironment (TME). For instance, immune checkpoints (e.g., programmed death protein 1 [PD-1]/programmed ligand [PD-L1]) TME play an important role inhibiting proliferation and functions. Transforming growth factor β (TGF)-β secreted cancer cells induces regulatory (Tregs) inhibits...

10.1016/j.omto.2021.03.014 article EN cc-by-nc-nd Molecular Therapy — Oncolytics 2021-04-02

Abstract Multidrug combination therapy provides an effective strategy for malignant tumor treatment. This paper presents the development of a biodegradable microrobot on‐demand multidrug delivery. By combining magnetic targeting transportation with therapy, it is hypothesized that loading multiple drugs on different regions single can enhance synergistic effect cancer The using two together greater than each drug separately. Here, 3D‐printed inspired by fish structure three hydrogel...

10.1002/smll.202301889 article EN Small 2023-07-09

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTEffects of Geometric Isomerism and Ligand Substitution in Bifunctional Dinuclear Platinum Complexes on Binding Properties Conformational Changes DNAN. Farrell, T. G. Appleton, Y. Qu, J. D. Roberts, A. P. Soares Fontes, K. Skov, Wu, ZouCite this: Biochemistry 1995, 34, 47, 15480–15486Publication Date (Print):November 1, 1995Publication History Published online1 May 2002Published inissue 1 November...

10.1021/bi00047a013 article EN Biochemistry 1995-11-01

Hydrophilic Fe3O4-Au Janus nanoparticles have been synthesized through a facile aqueous solution-based Fe3O4 seed-mediated chemical reduction route, where Au can be in situ formed on surfaces of PVP-modified by adopting the well-known citrate route. The diameter controllably tuned range 3-12 nm simply changing initial molar ratio between sodium and auric acid. as-fabricated hydrophilic shown excellent catalytic performance with high activity recyclability due to synergetic effect nanoparticles.

10.1021/acs.langmuir.6b01269 article EN Langmuir 2016-04-22

In order to establish fundamental structural requirements for the antitumor activation of trans-platinum geometry, complexes general formulas [PtCl(2)(NH(3))L] (L = planar N donor) have been synthesized. The trans isomers, trans-[PtCl(2)(NH(3))(quinoline)] (3), trans-[PtCl(2)(NH(3))(thiazole)] (5), trans-[PtCl(2)(NH(3))(benzothiazole)] (7), and trans-[PtCl(2)(NH(3))(isoquinoline)] (8) cis isomers cis-[PtCl(2)(NH(3))(quinoline)] (4) cis-[PtCl(2)(NH(3))(thiazole)] (6) were characterized by...

10.1021/ic981181x article EN Inorganic Chemistry 1999-07-01

Reported here is a detailed study of the kinetics and mechanism formation 1,4 GG interstrand cross-link by [{trans-PtCl(NH3)2}2(μ-NH2(CH2)nNH2)]2+ (1,1/t,t (n = 6), 1), prototype novel class platinum antitumor complexes. The reaction self-complementary 12-mer duplex 5'-{d(ATATGTACATAT)2} with 15N-1 has been studied at 298 K, pH 5.4, [1H,15N] HSQC 2D NMR spectroscopy. Initial electrostatic interactions are observed for 1 monoaqua monochloro species (2). Aquation to yield 2 occurs...

10.1021/ja0012772 article EN Journal of the American Chemical Society 2001-01-25

A new approach to the synthesis of novel bifunctional dinuclear platinum complexes with linear coordinating spermidine and spermine is reported. The synthetic pathway involves first three-step selective protection polyamines, giving bis(trifluoroacetyl)polyamines (1, 4), (tert-butoxycarbonyl)bis(trifluoroacetyl)polyamines (2, 5), (tert-butoxycarbonyl)polyamines (3, 6), respectively. platination at desired sites activated species cis- or trans-[PtCl2(NH3)2] (CDDP TDDP, respectively) produces...

10.1021/ic9701827 article EN Inorganic Chemistry 1997-08-01

A possible explanation for the low bioavailability of platinum antitumor compounds is their high reactivity with sulfur-containing tripeptide glutathione (GSH; deprotonated GSH = SG). located in intracellular matrix cell a normal concentration 5−10 mM. In vivo, only small fraction administered drug will migrate into cell, resulting relatively concentrations compared to that drug. The products reactions [{trans-PtCl(NH3)2}2-μ-{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)4 (BBR3464; 1,0,1/t,t,t, n 6),...

10.1021/ic030045b article EN Inorganic Chemistry 2003-08-07

Bis(platinum) complexes [{cis-PtCl2(NH3)}2H2N(CH2)nNH2] are a novel series of potential anticancer agents in which two cis-diamine(platinum) groups linked by an alkyldiamine variable length. These potentially tetrafunctional, unique feature comparison with known agents. Studies DNA interactions bis(platinum) cisplatin demonstrate significant differences. Investigations interstrand crosslink formation crosslinking short fragment is detected gel electrophoresis under denaturing conditions that...

10.1093/nar/17.23.9719 article EN Nucleic Acids Research 1989-01-01

The substitution-inert polynuclear platinum(II) complex (PPC) series, [{trans-Pt(NH3)2(NH2(CH2)nNH3)}2-μ-(trans-Pt(NH3)2(NH2(CH2)nNH2)2}](NO3)8, where n = 5 (AH78P), 6 (AH78 TriplatinNC) and 7 (AH78H), are potent non-covalent DNA binding agents nucleic acid recognition is achieved through use of the 'phosphate clamp' square-planar tetra-am(m)ine Pt(II) coordination units all form bidentate N–O–N complexes hydrogen bonding with phosphate oxygens. modular nature PPC–DNA interactions results in...

10.1093/nar/gku1157 article EN cc-by-nc Nucleic Acids Research 2014-11-20

Chimeric antigen receptor (CAR) T cell therapy mediates unprecedented benefit in certain leukemias and lymphomas, but has yet to achieve similar success combating solid tumors. A substantial body of work indicates that the accumulation adenosine tumor microenvironment (TME) plays a crucial role abrogating immunotherapies. Adenosine deaminase 1 (ADA) catabolizes into inosine is indispensable for functional immune system. We have, first time, engineered CAR cells overexpress ADA. To...

10.1089/hum.2021.050 article EN Human Gene Therapy 2021-07-06

The novel platinum drugs [{trans-PtCl(NH3)2}2H2N(CH2)nNH2]2+ (1,1/t,t) are currently undergoing preclinical development. bifunctional DNA binding of these agents allows comparison with that cisplatin [Farrell et al. (1995) Biochemistry, 34, 15480]. major lesion cisplatin, the 1,2-d(GpG) intrastrand adduct, produces a rigid, directed bend 30−35° into groove DNA. We have now completed structural analysis corresponding adduct formed dinuclear complexes. Gel retardation assays on 15−22 bp...

10.1021/bi961160j article EN Biochemistry 1996-01-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTInteraction of bis(platinum) complexes with the mononucleotide 5'-guanosine monophosphate. Effect diamine linker and nature complex on product formationYun Qu Nicholas FarrellCite this: J. Am. Chem. Soc. 1991, 113, 13, 4851–4857Publication Date (Print):June 1, 1991Publication History Published online1 May 2002Published inissue 1 June 1991https://pubs.acs.org/doi/10.1021/ja00013a021https://doi.org/10.1021/ja00013a021research-articleACS...

10.1021/ja00013a021 article EN Journal of the American Chemical Society 1991-06-01

The reactions of bis(platinum) complexes general formula [(PtClm(NH3)3-m)2(NH2(CH2)nNH2)]2(2-m)+ were studied with poly(dG-dC).poly(dG-dC), poly(dG-m5dC).poly(dG-m5dC) and poly(dG).poly(dC). When m = 0 (Complexes II, n 2,4) the are saturated 4+ cations capable only electrostatic interactions polynucleotide. Where 1 contain two monodentate platinum coordination spheres chloride trans to diamine bridge I, 2,4, 1,1/t,t). Complexes I give CD spectra characteristic a 'Z-like' conformation upon...

10.1093/nar/20.7.1697 article EN Nucleic Acids Research 1992-01-01
Coming Soon ...